MAN1A1 and breast carcinoma: For instance, low expression of MAN1A1 preserves the slow-cycling state and tumorigenicity of CD133 + GSCs23, and reduces adhesion capabilities breast cancer cells, leading to a poorer prognosis17, whereas high expression of MAN1A1 has been associated with a poor prognosis in hepatocarcinoma25 and ovarian cancer16.